MedPath

A Study Into the Effectivity and Safety of Firmagon, Prescribed for Treatment of Patients With Advanced Prostate Cancer

Completed
Conditions
Prostate Cancer
Registration Number
NCT01215526
Lead Sponsor
Ferring Pharmaceuticals
Brief Summary

Patients eligible for hormone ablation therapy who are prescribed Firmagon will be followed for a maximum of 3 years to estimate the progression free survival. Data on testosteron levels, QoL and LUTS will be collected if this information is available. Safety information (adverse events) will be collected.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
274
Inclusion Criteria
  • Patients with advanced hormone-dependent prostate carcinoma that are eligible for hormone therapy
Exclusion Criteria
  • Patients with a contraindication for prescription of Firmagon®

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To estimate the progression-free survival (PFS) failure rateMaximum 3 years
Secondary Outcome Measures
NameTimeMethod
To prescribe the change in patient's quality of life (QoL) during therapy.From study start and after 6 months
To enhance the knowledge on known undesirable effects under routine conditions and to obtain further knowledge about so far unknown and rare undesired effectsEvery 3 months (during 3 years)
To assess the improvement of IPSS from baseline after 3 months of Firmagon therapy and at end-of-therapyFrom study start, after 3 months and at end of treatment
To assess the reduction of prostate volume (neoadjuvant therapy)Fom baseline after 3 months

Trial Locations

Locations (45)

Flevoziekenhuis

🇳🇱

Almere, Netherlands

Bovenij Ziekenhuis

🇳🇱

Amsterdam, Netherlands

Wilhelminaziekenhuis

🇳🇱

Assen, Netherlands

Rode Kruis Ziekenhuis

🇳🇱

Beverwijk, Netherlands

Tergooiziekenhuizen

🇳🇱

Hilversum, Netherlands

Ljsselland Ziekenhuis

🇳🇱

Capelle aan den IJssel, Netherlands

Jeroen Bosch Ziekenhuis, locatie Carolus

🇳🇱

Den Bosch, Netherlands

Hagaziekenhuis loc. Leyweg

🇳🇱

Den Haag, Netherlands

Hagaziekenhuis loc. Sportlaan

🇳🇱

Den Haag, Netherlands

Alb.Schweitzer Ziekenhuis, loc. Dordwijk

🇳🇱

Dordrecht, Netherlands

Gelderse Vallei, loc. Barneveld

🇳🇱

Ede, Netherlands

St. Anna Ziekenhuis

🇳🇱

Geldrop, Netherlands

Admiraal de Ruyter Ziekenhuis

🇳🇱

Vlissingen, Netherlands

Buitenpolikliniek

🇳🇱

Groenlo, Netherlands

Ziekenhuis St Jansdal

🇳🇱

Harderwijk, Netherlands

LUMC

🇳🇱

Leiden, Netherlands

Rijnland Ziekenhuis

🇳🇱

Leiderdorp, Netherlands

MUMC

🇳🇱

Maastricht, Netherlands

Vlietland Ziekenhuis

🇳🇱

Rotterdam, Netherlands

Alb. Schweitzer Ziekenhuis loc. Sliedrecht

🇳🇱

Sliedrecht, Netherlands

Antonius Ziekenhuis

🇳🇱

Sneek, Netherlands

Ruwaard v Putten/vWeel Bethesda Zkhs

🇳🇱

Spijkenisse, Netherlands

Ziekenhuis Bernhoven, loc. Veghel

🇳🇱

Veghel, Netherlands

St. Jans Gasthuis

🇳🇱

Weert, Netherlands

Albert Schweitzer Ziekenhuis

🇳🇱

Zwijndrecht, Netherlands

Amphia Ziekenhuis

🇳🇱

Breda, Netherlands

Reinier de Graaf Groep

🇳🇱

Delft, Netherlands

Deventer Ziekenhuis

🇳🇱

Deventer, Netherlands

Slingeland Ziekenhuis

🇳🇱

Doetinchem, Netherlands

Rivas Beatrixziekenhuis

🇳🇱

Gorinchem, Netherlands

Het Groene Hart Ziekenhuis

🇳🇱

Gouda, Netherlands

Martini Ziekenhuis

🇳🇱

Groningen, Netherlands

Elkerliek Ziekenhuis

🇳🇱

Helmond, Netherlands

Medisch Centrum Leeuwarden

🇳🇱

Leeuwarden, Netherlands

Ziekenhuis Bernhoven, loc. Oss

🇳🇱

Oss, Netherlands

Waterland Ziekenhuis

🇳🇱

Purmerend, Netherlands

Franciscus Ziekenhuis

🇳🇱

Roosendaal, Netherlands

Havenziekenhuis

🇳🇱

Rotterdam, Netherlands

Orbis Medisch Centrum

🇳🇱

Sittard-Geleen, Netherlands

Zorgzaam Ziekenhuis

🇳🇱

Terneuzen, Netherlands

Ziekenhuis Rivierenland

🇳🇱

Tiel, Netherlands

Antonius Ziekenhuis, loc. Oudenrijn

🇳🇱

Utrecht, Netherlands

Diakonessenhuis Utrecht

🇳🇱

Utrecht, Netherlands

Maxima Medisch Centrum

🇳🇱

Veldhoven, Netherlands

Isala Klinieken

🇳🇱

Zwolle, Netherlands

© Copyright 2025. All Rights Reserved by MedPath